212 related articles for article (PubMed ID: 12447689)
1. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
4. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
5. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
6. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Pantic M; Zimmermann S; Waller CF; Martens UM
Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
[TBL] [Abstract][Full Text] [Related]
7. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of tumor cells after induction of telomere dysfunction.
Zimmermann S; Biniossek ML; Pantic M; Pfeifer D; Veelken H; Martens UM
Proteomics; 2009 Feb; 9(3):521-34. PubMed ID: 19132685
[TBL] [Abstract][Full Text] [Related]
9. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
Tauchi T; Shin-ya K; Sashida G; Sumi M; Okabe S; Ohyashiki JH; Ohyashiki K
Oncogene; 2006 Sep; 25(42):5719-25. PubMed ID: 16652154
[TBL] [Abstract][Full Text] [Related]
11. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
Horikawa I; Barrett JC
Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
14. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
15. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
16. Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.
Bakalova R; Ohba H; Zhelev Z; Kubo T; Fujii M; Ishikawa M; Shinohara Y; Baba Y
FEBS Lett; 2004 Apr; 564(1-2):73-84. PubMed ID: 15094045
[TBL] [Abstract][Full Text] [Related]
17. Strict control of telomerase activation using Cre-mediated inversion.
Ungrin MD; Harrington L
BMC Biotechnol; 2006 Feb; 6():10. PubMed ID: 16504006
[TBL] [Abstract][Full Text] [Related]
18. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
19. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
Nakajima A; Tauchi T; Sashida G; Sumi M; Abe K; Yamamoto K; Ohyashiki JH; Ohyashiki K
Leukemia; 2003 Mar; 17(3):560-7. PubMed ID: 12646945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
